Gene polymorphism of the renin-angiotensin system associates with risk for lacunar infarction: The Ohasama study

American Journal of Hypertension

Volumn 13, Issue 2, 2000, Pages 121-127

  Takami, Seiju ^a   Imai, Yutaka ^b   Katsuya, Tomohiro ^a   Ohkubo, Takayoshi ^b   Tsuji, Ichiro ^b   Nagai, Kenichi ^c   Satoh, Hiroshi ^b   Hisamichi, Shigeru ^b   Higaki, Jitsuo ^a   Ogihara, Toshio ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Ohasama Hospital   (Japan)

Author keywords

Genetics; Lacunar infarction; Periventricular hyperintensity (PVH); Polymorphism; Renin angiotensin system

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BRAIN REGION; CEREBROVASCULAR DISEASE; DNA POLYMORPHISM; FEMALE; GENE ISOLATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGED; ALLELES; ANGIOTENSIN I; ANGIOTENSIN II; BRAIN; BRAIN INFARCTION; DNA; FEMALE; GENOTYPE; HUMANS; INCIDENCE; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; RURAL POPULATION;

EID: 17344393902     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(99)00184-3     Document Type: Article

References (38)

1. Brass L.M., Issacsohn J.L., Merikangas K.R., Robinette C.D. A study of twins and stroke. Stroke. 23:1992;221-223.
2. Graffagnino C., Gasecki A.P., Doig G.S., Hachinski V.C. The importance of family history in cerebrovascular disease. Stroke. 25:1994;1599-1604.
3. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 51:1992;197-205.
4. Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P., Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 86:1990;1343-1346.
5. Nakai K., Itoh C., Miura Y., Hotta K., Musha T., Itoh T., Miyakawa T., Iwasaki R., Hiramori K. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation. 90:1994;2199-2202.
6. Harrap S.B., Davidson H.R., Connor J.M., Soubrier F., Corvol P., Fraser R., Foy C.J.W., Watt G.C.M. The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension. 21:1993;455-460.
7. Cambien F., Poirier O., Lecerf L., Evans A., Cambou J.-P., Arveiler D., Luc G., Bard J.-M., Bara L., Ricard S., Tiret L., Amouyel P., Alhenc-Gelas F., Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 359:1992;641-644.
8. Zhao Y., Higashimori K., Higaki J., Kamitani A., Ohishi M., Katsuya T., Miki T., Mikami H., Minamino T., Ogihara T. Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res. 17:1994;55-57.
9. Leatham E., Barley J., Redwood S., Hussein W., Carter N., Jeffery S., Bath P.M.W., Camm A. Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens. 8:1994;635-638.
10. Ludwig E., Corneli P.S., Anderson J.L., Marshall H.W., Lalouel J.-M., Ward R.H. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation. 91:1995;2120-2124.
11. Raynolds M.V., Bristow M.R., Bush E.W., Abraham W.T., Lowes B.D., Zisman L.S., Taft C.S., Perryman M.B. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet. 342:1993;1073-1075.
12. Markus H.S., Barley J., Lunt R., Bland J.M., Jeffery S., Carter N.D., Brown M.M. Angiotensin-converting enzyme gene deletion polymorphism a new risk factor for lacunar stroke but not carotid atheroma . Stroke. 26:1995;1329-1333.
13. Kario K., Kanai N., Saito K., Nago N., Matsuo T., Shimada K. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation. 93:1996;1630-1633.
14. Ueda S., Weir C.J., Inglis G.C., Murray G.D., Muir K.W., Lees K.R. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens. 13:1995;1597-1601.
15. Sharma P., Carter N.D., Barley J., Brown M.M. Molecular approach to assessing the genetic risk of cerebral infarction deletion polymorphism in the gene encoding angiotensin 1-converting enzyme . J Hum Hypertens. 8:1994;645-648.
16. Watanabe Y., Ishigami T., Kawano Y., Umahara T., Nakamori A., Mizushima S., Hibi K., Kobayashi I., Tamura K., Ochiai H., Umemura S., Ishii M. Angiotensin-converting enzyme gene I/D polymorphism and carotid plaques in Japanese. Hypertension. 30:1997;569-573.
17. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., Lalouel J.-M., Corvol P. Molecular basis of human hypertension role of angiotensinogen . Cell. 71:1992;169-180.
18. Bloem L.J., Manatunga A.K., Tewksbury D.A., Pratt J.H. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 95:1995;948-953.
19. Hata A., Namikawa C., Sasaki M., Sato K., Nakamura T., Tamura K., Lalouel J.-M. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest. 93:1994;1285-1287.
20. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., Clark A.J.L. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 330:1994;1629-1633.
21. Caulfield M., Lavender P., Newell-Price J., Farrall M., Kamdar S., Daniel H., Lawson M., Freitas P.D., Fogarty P., Clark A.J.L. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 96:1995;687-692.
22. Kamitani A., Rakugi H., Higaki J., Yi Z., Mikami H., Miki T., Ogihara T. Association analysis of a polymorphism of the angiotensinogen gene with essential hypertension in Japanese. J Hum Hypertens. 8:1994;521-524.
23. Kamitani A., Rakugi H., Higaki J., Ohishi M., Shi S.-J., Takami S., Nakata Y., Higashino Y., Fujii K., Mikami H., Miki T., Ogihara T. Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension. 25:1995;950-953.
24. Tiret L., Bonnardeaux A., Poirier O., Ricard S., Marques-Vidal P., Evans A., Arveiler D., Luc G., Kee F., Ducimetiere P., Soubrier F., Cambien F. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet. 344:1994;910-913.
25. Bonnardeaux A., Davies E., Jeunemaitre X., Fery I., Charru A., Clauser E., Tiret L., Cambien F., Corvol P., Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 24:1994;63-69.
26. Imai Y., Nagai K., Sakuma M., Sakuma H., Nakatsuka H., Satoh H., Minami N., Munakata M., Hashimoto J., Yamagishi T., Watanabe N., Yabe T., Nishiyama A., Abe K. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension. 22:1993;900-912.
27. Imai Y., Satoh H., Nagai K., Sakuma M., Sakuma H., Minami N., Munakata M., Hashimoto J., Yamagishi T., Watanabe N., Yabe T., Nishiyama A., Nakatsuka H., Koyama H., Abe K. Characteristics of a community-based distribution of home blood pressure in Ohasama in northern Japan. J Hypertens. 11:1993;1441-1449.
28. Tsuji I., Imai Y., Nagai K., Ohkubo T., Watanabe N., Minami N., Itoh O., Bando T., Sakuma M., Fukao A., Satoh H., Hisamichi S., Abe K. Proposal of reference values for home blood pressure measurement. Am J Hypertens. 10:1997;409-418.
29. Ohkubo T., Imai Y., Tsuji I., Nagai K., Watanabe N., Minami N., Itoh O., Bando T., Sakuma M., Fukao A., Satoh H., Hisamichi S., Abe K. Prediction of mortality by ambulatory blood pressure monitoring versus screening blood pressure measurements a pilot study in Ohasama . J Hypertens. 15:1997;357-364.
30. Ohkubo T., Imai Y., Tsuji I., Nagai K., Watanabe N., Minami N., Kato J., Kikuchi N., Nishiyama A., Aihara A., Sekino M., Satoh H., Hisamichi S. Relation between nocturnal decline in blood pressure and mortality. Am J Hypertens. 10:1997;1201-1207.
31. Watanabe N., Imai Y., Nagai K., Tsuji I., Satoh H., Sakuma M., Sakuma H., Kato J., Onodera-Kikuchi N., Yamada M., Abe F., Hisamichi S., Abe K. Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke. 27:1996;1319-1327.
32. Lindpaintner K., Pfeffer M.A., Kreutz R., Stampfer M.J., Grodstein F., LaMotte F., Buring J., Hennekens C.H. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 332:1995;706-711.
33. Benetos A., Topouchian J., Ricard S., Gautier S., Bonnardeaux A., Asmar R., Poirier O., Soubrier F., Safar M., Cambien F. Influence of angiotensin II type 1 receptor polymorphism on aortic stiffness in never-treated hypertensive patients. Hypertension. 26:1995;44-47.
34. Benetos A., Gautier S., Ricard S., Topouchian J., Asmar R., Poirier O., Larosa E., Guize L., Safar M., Soubrier F., Cambien F. Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation. 94:1996;698-703.
35. Jeunemaitre X., Lifton R.P., Hunt S.C., Williams R.R., Lalouel J.-M. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet. 1:1992;72-75.
36. Kiema T.-R., Kauma H., Rantala A.O., Lilja M., Reunanen A., Kesaniemi Y.A., Savolainen M.J. Variation at the angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension. 28:1996;1070-1075.
37. Gaillard I., Clauser E., Corvol P. Structure of human angiotensinogen gene. DNA. 8:1989;87-99.
38. Hayashi T., Suzuki K. Gene organization of human protein C inhibitor, a member of SERPIN family proteins encoded in five exons. Int J Hematol. 58:1993;213-224.